Market Overview:
The global fenofibric acid market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and other lifestyle diseases, rising awareness about the benefits of fenofibric acid, and growing demand for cost-effective treatment options. The global fenofibric acid market is segmented on the basis of type, application, and region. On the basis of type, it is divided into 45 mg and 135 mg segments. The 45 mg segment is expected to account for a larger share in terms of revenue in 2018 owing to its lower price point as compared to 135 mg segment. However, with increasing awareness about the benefits offered by higher doses of fenofibric acid such as weight loss and better lipid profile management, the 135 mg segment is projected to grow at a higher CAGR during the forecast period from 2018-2030. On the basis of application, it is classified into hospital and drug store segments. The hospital segment accounted for a larger share in terms revenue in 2017 due high adoption rates across developed countries such as U S.
Product Definition:
Fenofibric acid is a drug used to lower cholesterol levels and triglycerides in the blood. It is similar to a statin but may be used when other statins are not tolerated or effective. Fenofibrate also appears to reduce the risk of heart attack, stroke, and death in people with type 2 diabetes.
45 mg:
45 mg is used for the treatment of hereditary angioedema, which is a rare chronic condition characterized by excessive production of fibrinogen and thromboxane. The high amount of fibrinogen in the blood leads to severe swelling in the face, legs, arms and other parts of the body.
135 mg:
Fenofibric acid is a naturally occurring compound and has been reported to have anti-inflammatory properties. It can be found in certain plants, such as fenugreek, sweet clover, and weeds.
Application Insights:
The major application of fenofibric acid includes hospital and drug stores. The demand for the product in hospitals is expected to witness growth owing to its antibacterial, antidiabetic, antioxidant and anti-inflammatory properties. It also helps in treating constipation by increasing the transit time of stool. In addition, it has been proven helpful in reducing blood cholesterol levels as well as preventing cardiovascular diseases.
Hospital application was the largest segment with a market share of over 60% in 2017 on account of rising awareness regarding healthcare services among consumers across various regions coupled with growing investments by governments for developing healthcare infrastructure at a global level is anticipated to drive demand over the forecast period.
Regional Analysis:
Asia Pacific was the largest market in 2016 and is expected to continue its dominance over the forecast period. The region accounts for approximately 60% of global pharmaceuticals industry, which has led to a high penetration of product usage in this region. Rising geriatric population coupled with increasing healthcare spending by local governments is also likely to drive demand for pharmaceutical products, thereby supporting market growth.
In addition, growing awareness regarding personal care products that contain natural ingredients along with low VOC emissions has resulted in increased demand from end-use industries such as cosmetics and personal care. This factor is anticipated to further fuel regional product consumption over the forecast period. However, recent outbreak of COVID-19 across countries such as China and India may hamper consumer confidence towards these beauty products resulting into lower sales volumes than expected; however it will affect second half or third quarter sales estimates only marginally due to Chinese New Year holidays or other seasonal breaks between seasons like Easter etc.
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Rising geriatric population
- Growing demand for minimally invasive surgeries
- Technological advancements in fenofibrate drugs
- increasing awareness about the benefits of fenofibrate therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Fenofibric Acid Market Research Report
By Type
45 mg, 135 mg
By Application
Hospital, Drug Store
By Companies
AbbVie, Lupin, Impax Laboratories, Mylan, Alembic Pharmaceuticals, Par Pharmaceutical, AbbVie
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Fenofibric Acid Market Report Segments:
The global Fenofibric Acid market is segmented on the basis of:
Types
45 mg, 135 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Lupin
- Impax Laboratories
- Mylan
- Alembic Pharmaceuticals
- Par Pharmaceutical
- AbbVie
Highlights of The Fenofibric Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 45 mg
- 135 mg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fenofibric Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fenofibric acid is a type of fatty acid that is found in plant-based oils and fats. Fenofibric acid can help to improve the texture, shine, and elasticity of hair.
Some of the major players in the fenofibric acid market are AbbVie, Lupin, Impax Laboratories, Mylan, Alembic Pharmaceuticals, Par Pharmaceutical, AbbVie.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fenofibric Acid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fenofibric Acid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fenofibric Acid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fenofibric Acid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fenofibric Acid Market Size & Forecast, 2020-2028
4.5.1 Fenofibric Acid Market Size and Y-o-Y Growth
4.5.2 Fenofibric Acid Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 45 mg
5.2.2 135 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fenofibric Acid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fenofibric Acid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 45 mg
9.6.2 135 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 45 mg
10.6.2 135 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 45 mg
11.6.2 135 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 45 mg
12.6.2 135 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 45 mg
13.6.2 135 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fenofibric Acid Market: Competitive Dashboard
14.2 Global Fenofibric Acid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Lupin
14.3.3 Impax Laboratories
14.3.4 Mylan
14.3.5 Alembic Pharmaceuticals
14.3.6 Par Pharmaceutical
14.3.7 AbbVie
